Einträge von Giralt, Sergio auf dem Publikationsserver
![]() | Eine Stufe nach oben |
Anzahl der Einträge: 2.
2020
van den Brink, Marcel R. M., Cross, Justin R.
, Peled, Jonathan U.
, Sung, Anthony D., Xavier, Joao
, Devlin, Sean M., Ponce, Doris M., Perales, Miguel-Angel, Holler, Ernst
, Pamer, Eric G., Taur, Ying, Giralt, Sergio, Politikos, Ioannis, Cho, Christina, Maloy, Molly, Chao, Nelson, Rizzieri, David A., Lew, Meagan V.
, Covington, Megan, Bohannon, Lauren, Bush, Amy, Rao, Arka, Ramos, Ruben J., Clurman, Annelie G., Brereton, Daniel G., Nichols, Katherine B., Slingerland, John B., Slingerland, Ann E., Armijo, Gabriel K., Docampo, Melissa D., Dai, Anqi, Weber, Daniela, Giardina, Paul A., Taylor, Bradford P., Pickard, Amanda J., Littmann, Eric R., Gomes, Antonio L. C., Schluter, Jonas und Markey, Kate A.
(2020)
The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD.
Blood 136 (1), S. 130-136.
Volltext nicht vorhanden.
, Peled, Jonathan U.
, Sung, Anthony D., Xavier, Joao
, Devlin, Sean M., Ponce, Doris M., Perales, Miguel-Angel, Holler, Ernst
, Pamer, Eric G., Taur, Ying, Giralt, Sergio, Politikos, Ioannis, Cho, Christina, Maloy, Molly, Chao, Nelson, Rizzieri, David A., Lew, Meagan V.
, Covington, Megan, Bohannon, Lauren, Bush, Amy, Rao, Arka, Ramos, Ruben J., Clurman, Annelie G., Brereton, Daniel G., Nichols, Katherine B., Slingerland, John B., Slingerland, Ann E., Armijo, Gabriel K., Docampo, Melissa D., Dai, Anqi, Weber, Daniela, Giardina, Paul A., Taylor, Bradford P., Pickard, Amanda J., Littmann, Eric R., Gomes, Antonio L. C., Schluter, Jonas und Markey, Kate A.
(2020)
The microbe-derived short-chain fatty acids butyrate and propionate are associated with protection from chronic GVHD.
Blood 136 (1), S. 130-136.
Volltext nicht vorhanden.
2012
Richardson, Paul M., Ho, Vincent T., Giralt, Sergio, Arai, Sally, Mineishi, Shin, Cutler, C., Antin, Joseph H., Stavitzski, N., Niederwieser, N. und Holler, Ernst
(2012)
Safety and efficacy of defibrotide for the treatment of severe hepatic veno-occlusive disease.
Therapeutic Advances in Hematology 3, S. 253-265.
